Feature Stories

Featured News:

Alzheimer’s Disease Research at the Weizmann Institute of Science

At the Weizmann Institute, scientists from a range of disciplines are investigating the causes and nature of Alzheimer's disease, as well as looking for ways to slow or stop its progress, and for new and better treatments.

article thumbnail
Autism Research at the Weizmann Institute of Science

More and more children are being diagnosed with autism and related conditions, with the Centers for Disease Control (CDC) estimating that about 1 in 88 children has been diagnosed with an autism spectrum disorder (ASD). Fortunately, Weizmann researchers from a number of disciplines are working together to unravel the mysteries of ASDs.

article thumbnail
Vision Research at the Weizmann Institute of Science

Weizmann scientists are conducting active vision research, with projects ranging from the basic biochemistry of the retina to studies of vision and the brain in action. Interdisciplinary groups study computer-aided and artificial vision and experiment with vaccines to prevent degenerative diseases.

March 01, 2013

article thumbnail
What the Weizmann Institute is Doing About Heart Disease

According to the American Heart Association, more than 80 million Americans have one or more forms of cardiovascular disease. Weizmann researchers are not only searching for solutions to this health epidemic, but are also investigating the very earliest causes, such as problems during embryonic formation.

February 01, 2013

article thumbnail
Cancer at a Breaking Point

Like police detectives using DNA fingerprinting, Weizmann cancer researchers are building a DNA profile of malignancy in an attempt to eradicate cancer.

December 16, 2012

article thumbnail
What the Weizmann Institute is Doing to Fight World Hunger

Weizmann scientists are unlocking the secrets of plant metabolism, genetics, and development and are concentrating their biochemical, molecular, and genomics-oriented research to eliminate hunger and malnutrition in developing countries, and to improve human health all over the world.

December 11, 2012

article thumbnail
What I Learned

Weizmann President Prof. Daniel Zajfman speaks to Haaretz about knowledge, curiosity, and passion – his recipe for success – and how he has applied this formula to developing long-term strategies for the Institute. He also talks about finding happiness in work and in life: “Ask yourself what you love to do – and then do it.”

December 02, 2012

article thumbnail
The Enigmatic Sphingolipid: Its Role in Genetic Disease

Prof. Tony Futerman studies lipids – fatty substances found in every cell in our bodies. A type called sphingolipids builds up in harmful amounts due to some genetic diseases, such as Gaucher’s. Understanding this process could lead to new and better therapies.

September 01, 2012

article thumbnail
Leukemia and Lymphoma Research

Blood cancers, such as lymphoma and leukemia, arise due to errors in the genetic information of an immature blood cell – and they often affect children. In fact, leukemia alone is responsible for 40 percent of pediatric cancers. Read how Weizmann scientists are helping.

September 01, 2012

article thumbnail
Back to the Future

Induced pluripotent stem cells – reprogrammed adult cells – could someday be used to treat a range of diseases. However, scientists still don’t know exactly what happens inside the “black box” of the reprogramming process. Dr. Yaqub Hanna and his team have now shed light on this mystery.

August 28, 2012

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. Next page

Stay up to date with Tomorrow Lab

Our scientists are listening

Make a donation and tell Weizmann scientists about the research you’d like them to
pursue to make tomorrow better
Learn more